HUTCHMED (HCM) News Today → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free HCM Stock Alerts GBX 346.10 +8.10 (+2.40%) (As of 06:11 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committeemarkets.businessinsider.com - May 8 at 4:54 AMHUTCHMED (LON:HCM) Shares Pass Above 200-Day Moving Average of $268.65americanbankingnews.com - May 3 at 3:38 AMHUTCHMED (China) (LON:HCM) shareholders are up 8.2% this past week, but still in the red over the last five yearsfinance.yahoo.com - April 24 at 5:28 AMHUTCHMED (China) Ltd ADRmorningstar.com - April 21 at 12:42 AMLONDON BRIEFING: JD Sports backs outlook; Spirent accepts new offerlse.co.uk - March 28 at 5:45 PMHCM Mar 2024 30.000 callfinance.yahoo.com - March 15 at 8:09 AMHUTCHMED Hold Rating: Cautious Optimism Amidst Stable Outlook and International Growth Potentialmarkets.businessinsider.com - February 28 at 11:15 PMHUTCHMED (China) Limited: HUTCHMED Reports 2023 Full Year Results and Provides Business Updatesfinanznachrichten.de - February 28 at 8:14 AMHutchison China MediTech reports FY resultsmsn.com - February 28 at 8:14 AMHUTCHMED Reports 2023 Full Year Results and Provides Business Updatesmarkets.businessinsider.com - February 28 at 8:14 AMHUTCHMED Turns To Profit In FY23, Revenue Surges; Stock Up In Pre-marketmarkets.businessinsider.com - February 28 at 8:14 AMHUTCHMED (China) Ltd (H7T2.BE)au.finance.yahoo.com - February 20 at 7:45 PMHUTCHMED (China) Limited's (LON:HCM) biggest owners are private equity firms who got richer after stock soared 4.3% last weekfinance.yahoo.com - February 20 at 4:43 AMWall Street Analysts See a 75.05% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?msn.com - February 19 at 12:25 PMMaintaining Hold on HUTCHMED: Mixed FRUTIGA Results and Fair Valuation Limit Upsidemarkets.businessinsider.com - February 7 at 10:35 AMHUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic Partnershipmarkets.businessinsider.com - February 2 at 8:08 AMHUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic Partnershipfinance.yahoo.com - February 2 at 8:08 AMHUTCHMED to Announce 2023 Final Resultsfinance.yahoo.com - February 1 at 7:03 AMHUTCHMED (China) Limited: HUTCHMED Receives ELUNATE (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal Cancerfinanznachrichten.de - January 30 at 6:36 PMHUTCHMED Announces Marketing Approval For ELUNATE By Pharmacy And Poisons Board Of Hong Kongmarkets.businessinsider.com - January 30 at 8:34 AMAfter Plunging -10.7% in 4 Weeks, Here's Why the Trend Might Reverse for HUTCHMED (HCM)msn.com - January 18 at 1:11 PMHUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology Congressesfinance.yahoo.com - November 30 at 7:13 PMHUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology Congressesfinance.yahoo.com - November 30 at 7:13 PMHUTCHMED (China) Limited - ADR (HCM) Price Target Increased by 5.11% to 26.63msn.com - November 27 at 8:18 PMHUTCHMED (China) Stock (NASDAQ:HCM), Analyst Ratings, Price Targets, Predictionsbenzinga.com - November 25 at 9:46 AMHUTCHMED’s Global Expansion and New Product Launches Bolster Buy Rating: An Analysis of Growth Prospects and Market Potentialmarkets.businessinsider.com - November 24 at 10:57 PMAnalysts Conflicted on These Healthcare Names: HUTCHMED (HCM), Bayer (OtherBAYRY) and Compass Therapeutics (CMPX)markets.businessinsider.com - November 10 at 1:40 AMHUTCHMED (China) Ltd HCMmorningstar.com - November 6 at 12:38 AMHUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2023benzinga.com - October 16 at 7:17 AMHUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2023finance.yahoo.com - October 16 at 7:17 AMHUTCHMED Announces Submission of New Drug Application for Fruquintinib for Previously Treated Metastatic Colorectal Cancer in Japanstockhouse.com - September 29 at 7:57 AMIs HUTCHMED (China) Ltd (HCM) Set to Underperform? Analyzing the Factors Limiting Growthfinance.yahoo.com - September 25 at 3:54 PMPrivate equity firms account for 44% of HUTCHMED (China) Limited's (LON:HCM) ownership, while institutions account for 28%finance.yahoo.com - September 13 at 3:01 AMHUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in Chinabenzinga.com - September 11 at 11:20 PMHUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in Chinafinance.yahoo.com - September 11 at 11:20 PMDecoding HUTCHMED (China) Ltd (HCM)'s Performance Potential: A Deep Dive into Key Metricsfinance.yahoo.com - September 11 at 6:20 PMHUTCHMED (China) Limited: HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancerfinanznachrichten.de - August 29 at 7:25 AMHUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancerfinance.yahoo.com - August 28 at 9:24 PMBank of America Securities Sticks to Its Buy Rating for HUTCHMED (HCM)markets.businessinsider.com - August 22 at 7:54 AMGoldman Sachs Remains a Hold on HUTCHMED (HCM)markets.businessinsider.com - August 21 at 4:52 PMHutchmed: Attractive Chinese R&D Giantmsn.com - August 11 at 7:55 PMHUTCHMED (China) First Half 2023 Earnings: EPS: US$0.20 (vs US$0.19 loss in 1H 2022)finance.yahoo.com - August 3 at 8:17 AMWall Street Analysts Think HUTCHMED (HCM) Could Surge 141.13%: Read This Before Placing a Betfinance.yahoo.com - July 19 at 2:17 PMHUTCHMED Initiates Phase I Study of its novel SHP2 inhibitor HMPL-415 for Advanced Malignant Solid Tumors in Chinafinance.yahoo.com - July 9 at 8:43 PMHUTCHMED to Announce 2023 Half-Year Financial Resultsfinance.yahoo.com - June 26 at 8:08 AMHUTCHMED (China) Limited: HUTCHMED and Takeda Announce Publication of Phase III FRESCO-2 Results in The Lancetfinanznachrichten.de - June 16 at 8:47 AMHUTCHMED (China) (LON:HCM investor five-year losses grow to 53% as the stock sheds UK£125m this past weekfinance.yahoo.com - June 1 at 10:06 AMHUTCHMED Highlights Presentations at the 2023 ASCO Annual Meetingfinance.yahoo.com - May 25 at 9:08 PMTakeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Reviewfinance.yahoo.com - May 25 at 9:08 PMHUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committeesbenzinga.com - May 10 at 5:51 AM Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. HCM Media Mentions By Week HCM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCM News Sentiment▼0.340.44▲Average Medical News Sentiment HCM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCM Articles This Week▼10▲HCM Articles Average Week Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INDV News Today HIK News Today GNS News Today EMIS News Today SPI News Today DPH News Today ONT News Today CRW News Today ERGO News Today CTEC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HCM) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap Profits[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
